HEADER IMMUNE SYSTEM 15-SEP-10 3OV6 TITLE CD1C IN COMPLEX WITH MPM (MANNOSYL-BETA1-PHOSPHOMYCOKETIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-2-MICROGLOBULIN, T-CELL SURFACE GLYCOPROTEIN CD1C, T- COMPND 3 CELL SURFACE GLYCOPROTEIN CD1B; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: BETA-2-MICROGLOBULIN; COMPND 6 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BTI-TN-5B1-4; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PACGP67A KEYWDS MHC, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, ANTIGEN PRESENTATION EXPDTA X-RAY DIFFRACTION AUTHOR L.SCHARF,N.S.LI,A.J.HAWK,D.GARZON,T.ZHANG,A.R.KAZEN,S.SHAH, AUTHOR 2 E.J.HADDADIAN,A.SAGHATELIAN,J.D.FARALDO-GOMEZ,S.C.MEREDITH, AUTHOR 3 J.A.PICCIRILLI,E.J.ADAMS REVDAT 3 29-JUL-20 3OV6 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 SSBOND LINK SITE REVDAT 2 26-JUL-17 3OV6 1 SOURCE REMARK REVDAT 1 19-JAN-11 3OV6 0 JRNL AUTH L.SCHARF,N.S.LI,A.J.HAWK,D.GARZON,T.ZHANG,L.M.FOX,A.R.KAZEN, JRNL AUTH 2 S.SHAH,E.J.HADDADIAN,J.E.GUMPERZ,A.SAGHATELIAN, JRNL AUTH 3 J.D.FARALDO-GOMEZ,S.C.MEREDITH,J.A.PICCIRILLI,E.J.ADAMS JRNL TITL THE 2.5 A STRUCTURE OF CD1C IN COMPLEX WITH A MYCOBACTERIAL JRNL TITL 2 LIPID REVEALS AN OPEN GROOVE IDEALLY SUITED FOR DIVERSE JRNL TITL 3 ANTIGEN PRESENTATION JRNL REF IMMUNITY V. 33 853 2010 JRNL REFN ISSN 1074-7613 JRNL PMID 21167756 JRNL DOI 10.1016/J.IMMUNI.2010.11.026 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.5_2) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.080 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 13644 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 686 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.5501 - 4.2769 0.97 2902 135 0.2423 0.2526 REMARK 3 2 4.2769 - 3.3951 0.97 2768 139 0.1976 0.2545 REMARK 3 3 3.3951 - 2.9661 0.96 2658 168 0.2343 0.2984 REMARK 3 4 2.9661 - 2.6949 0.90 2501 141 0.2818 0.2792 REMARK 3 5 2.6949 - 2.5018 0.76 2129 103 0.3560 0.4036 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 40.00 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.09240 REMARK 3 B22 (A**2) : 6.14990 REMARK 3 B33 (A**2) : -7.08930 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 3180 REMARK 3 ANGLE : 1.490 4301 REMARK 3 CHIRALITY : 0.095 446 REMARK 3 PLANARITY : 0.005 546 REMARK 3 DIHEDRAL : 23.146 1167 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3OV6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000061613. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.45 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14397 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CHES PH 9.45, 1.05M SODIUM REMARK 280 CITRATE, 25 MM TRIGLYCINE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.86200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.40400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.54350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.40400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.86200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.54350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 998 REMARK 465 ASP A 999 REMARK 465 SER A 1104 REMARK 465 GLY A 1105 REMARK 465 GLY A 1106 REMARK 465 SER A 1107 REMARK 465 GLY A 1108 REMARK 465 SER A 1109 REMARK 465 GLY A 1110 REMARK 465 GLY A 1111 REMARK 465 GLY A 1112 REMARK 465 SER A 1113 REMARK 465 SER A 1114 REMARK 465 ALA A 1 REMARK 465 ASP A 2 REMARK 465 ALA A 3 REMARK 465 SER A 4 REMARK 465 GLN A 5 REMARK 465 GLN A 87 REMARK 465 ASP A 88 REMARK 465 TYR A 89 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 SER A 1020 CA REMARK 480 GLU A 1044 CB CG CD OE1 OE2 REMARK 480 GLU A 1047 C REMARK 480 LYS A 1058 CG CD CE NZ REMARK 480 GLU A 1074 CB CG CD OE1 OE2 REMARK 480 LYS A 1075 CB CG CD CE NZ REMARK 480 GLN A 1089 CB CG CD OE1 NE2 REMARK 480 LYS A 1091 CG CD CE NZ REMARK 480 LYS A 1094 CD CE NZ REMARK 480 GLY A 1101 O REMARK 480 GLN A 21 C O CD OE1 NE2 REMARK 480 SER A 22 C O REMARK 480 GLU A 43 C O CD OE1 OE2 REMARK 480 GLN A 52 OE1 NE2 REMARK 480 GLU A 61 CB CG CD OE1 OE2 REMARK 480 ARG A 79 CG CD NE CZ NH1 NH2 REMARK 480 GLN A 82 CG CD OE1 NE2 REMARK 480 ASP A 83 CG OD1 OD2 REMARK 480 HIS A 84 CG ND1 CD2 CE1 NE2 REMARK 480 LYS A 91 CB CG CD CE NZ REMARK 480 TYR A 92 CB CG CD1 CD2 CE1 CE2 CZ REMARK 480 TYR A 92 OH REMARK 480 PHE A 126 CE2 REMARK 480 THR A 130 CB OG1 CG2 REMARK 480 CYS A 137 CB SG REMARK 480 LEU A 140 CG CD1 CD2 REMARK 480 GLN A 142 CG CD OE1 NE2 REMARK 480 SER A 143 CA REMARK 480 HIS A 146 N CA REMARK 480 LEU A 147 CG CD1 CD2 REMARK 480 HIS A 150 CA CB REMARK 480 GLN A 151 CB CG CD OE1 NE2 REMARK 480 TYR A 152 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 GLU A 153 CG CD OE1 OE2 REMARK 480 GLU A 157 CG CD OE1 OE2 REMARK 480 ARG A 164 C O NE CZ NH1 NH2 REMARK 480 LYS A 179 C O CE NZ REMARK 480 MET A 180 C O CE REMARK 480 ARG A 184 C O CD NE CZ NH1 NH2 REMARK 480 GLU A 189 OE2 REMARK 480 PRO A 216 N C REMARK 480 GLU A 225 CG CD OE1 OE2 REMARK 480 GLN A 226 CG CD OE1 NE2 REMARK 480 GLN A 229 CB CG CD OE1 NE2 REMARK 480 ASP A 235 CG OD1 OD2 REMARK 480 GLU A 256 CG CD OE1 OE2 REMARK 480 ARG A 263 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 270 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A1014 151.70 -49.04 REMARK 500 TRP A1060 0.34 88.96 REMARK 500 ASN A 20 -164.46 -160.60 REMARK 500 ASP A 33 -149.90 58.04 REMARK 500 GLN A 57 17.60 59.43 REMARK 500 HIS A 84 71.11 61.32 REMARK 500 LYS A 91 -155.60 -138.38 REMARK 500 TYR A 92 22.44 -145.96 REMARK 500 GLN A 128 58.75 33.60 REMARK 500 THR A 129 8.35 86.50 REMARK 500 SER A 165 -73.04 -112.99 REMARK 500 GLN A 241 40.01 -96.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 1106 DBREF 3OV6 A 1001 1099 UNP P61769 B2MG_HUMAN 21 119 DBREF 3OV6 A 1 183 UNP P29017 CD1C_HUMAN 19 201 DBREF 3OV6 A 184 278 UNP P29016 CD1B_HUMAN 201 295 SEQADV 3OV6 ALA A 998 UNP P61769 EXPRESSION TAG SEQADV 3OV6 ASP A 999 UNP P61769 EXPRESSION TAG SEQADV 3OV6 PRO A 1000 UNP P61769 EXPRESSION TAG SEQADV 3OV6 GLY A 1100 UNP P61769 LINKER SEQADV 3OV6 GLY A 1101 UNP P61769 LINKER SEQADV 3OV6 GLY A 1102 UNP P61769 LINKER SEQADV 3OV6 GLY A 1103 UNP P61769 LINKER SEQADV 3OV6 SER A 1104 UNP P61769 LINKER SEQADV 3OV6 GLY A 1105 UNP P61769 LINKER SEQADV 3OV6 GLY A 1106 UNP P61769 LINKER SEQADV 3OV6 SER A 1107 UNP P61769 LINKER SEQADV 3OV6 GLY A 1108 UNP P61769 LINKER SEQADV 3OV6 SER A 1109 UNP P61769 LINKER SEQADV 3OV6 GLY A 1110 UNP P61769 LINKER SEQADV 3OV6 GLY A 1111 UNP P61769 LINKER SEQADV 3OV6 GLY A 1112 UNP P61769 LINKER SEQADV 3OV6 SER A 1113 UNP P61769 LINKER SEQADV 3OV6 SER A 1114 UNP P61769 LINKER SEQADV 3OV6 GLN A 52 UNP P29017 ASN 70 ENGINEERED MUTATION SEQADV 3OV6 GLN A 57 UNP P29017 ASN 75 ENGINEERED MUTATION SEQADV 3OV6 GLY A 108 UNP P29017 LYS 126 ENGINEERED MUTATION SEQADV 3OV6 GLN A 128 UNP P29017 ASN 146 ENGINEERED MUTATION SEQADV 3OV6 GLN A 241 UNP P29016 ASN 258 ENGINEERED MUTATION SEQADV 3OV6 GLY A 242 UNP P29016 TRP 259 ENGINEERED MUTATION SEQADV 3OV6 HIS A 279 UNP P29016 EXPRESSION TAG SEQADV 3OV6 HIS A 280 UNP P29016 EXPRESSION TAG SEQRES 1 A 397 ALA ASP PRO ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SEQRES 2 A 397 SER ARG HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU SEQRES 3 A 397 ASN CYS TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU SEQRES 4 A 397 VAL ASP LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL SEQRES 5 A 397 GLU HIS SER ASP LEU SER PHE SER LYS ASP TRP SER PHE SEQRES 6 A 397 TYR LEU LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS SEQRES 7 A 397 ASP GLU TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER SEQRES 8 A 397 GLN PRO LYS ILE VAL LYS TRP ASP ARG ASP MET GLY GLY SEQRES 9 A 397 GLY GLY SER GLY GLY SER GLY SER GLY GLY GLY SER SER SEQRES 10 A 397 ALA ASP ALA SER GLN GLU HIS VAL SER PHE HIS VAL ILE SEQRES 11 A 397 GLN ILE PHE SER PHE VAL ASN GLN SER TRP ALA ARG GLY SEQRES 12 A 397 GLN GLY SER GLY TRP LEU ASP GLU LEU GLN THR HIS GLY SEQRES 13 A 397 TRP ASP SER GLU SER GLY THR ILE ILE PHE LEU HIS GLN SEQRES 14 A 397 TRP SER LYS GLY GLN PHE SER ASN GLU GLU LEU SER ASP SEQRES 15 A 397 LEU GLU LEU LEU PHE ARG PHE TYR LEU PHE GLY LEU THR SEQRES 16 A 397 ARG GLU ILE GLN ASP HIS ALA SER GLN ASP TYR SER LYS SEQRES 17 A 397 TYR PRO PHE GLU VAL GLN VAL LYS ALA GLY CYS GLU LEU SEQRES 18 A 397 HIS SER GLY GLY SER PRO GLU GLY PHE PHE GLN VAL ALA SEQRES 19 A 397 PHE ASN GLY LEU ASP LEU LEU SER PHE GLN GLN THR THR SEQRES 20 A 397 TRP VAL PRO SER PRO GLY CYS GLY SER LEU ALA GLN SER SEQRES 21 A 397 VAL CYS HIS LEU LEU ASN HIS GLN TYR GLU GLY VAL THR SEQRES 22 A 397 GLU THR VAL TYR ASN LEU ILE ARG SER THR CYS PRO ARG SEQRES 23 A 397 PHE LEU LEU GLY LEU LEU ASP ALA GLY LYS MET TYR VAL SEQRES 24 A 397 HIS ARG GLN VAL LYS PRO GLU ALA TRP LEU SER SER GLY SEQRES 25 A 397 PRO SER PRO GLY PRO GLY ARG LEU GLN LEU VAL CYS HIS SEQRES 26 A 397 VAL SER GLY PHE TYR PRO LYS PRO VAL TRP VAL MET TRP SEQRES 27 A 397 MET ARG GLY GLU GLN GLU GLN GLN GLY THR GLN LEU GLY SEQRES 28 A 397 ASP ILE LEU PRO ASN ALA GLN GLY THR TRP TYR LEU ARG SEQRES 29 A 397 ALA THR LEU ASP VAL ALA ASP GLY GLU ALA ALA GLY LEU SEQRES 30 A 397 SER CYS ARG VAL LYS HIS SER SER LEU GLU GLY GLN ASP SEQRES 31 A 397 ILE ILE LEU TYR TRP HIS HIS MODRES 3OV6 ASN A 20 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET D12 A1104 12 HET MK0 A1105 48 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM D12 DODECANE HETNAM MK0 1-O-[(S)-HYDROXY{[(4S,8S,16S,20S)-4,8,12,16,20- HETNAM 2 MK0 PENTAMETHYLHEPTACOSYL]OXY}PHOSPHORYL]-BETA-D- HETNAM 3 MK0 MANNOPYRANOSE FORMUL 2 NAG C8 H15 N O6 FORMUL 3 D12 C12 H26 FORMUL 4 MK0 C38 H77 O9 P FORMUL 5 HOH *38(H2 O) HELIX 1 1 ASP A 1096 GLY A 1100 5 5 HELIX 2 2 SER A 59 ASP A 83 1 25 HELIX 3 3 GLY A 138 GLN A 151 1 14 HELIX 4 4 GLY A 154 SER A 165 1 12 HELIX 5 5 SER A 165 VAL A 182 1 18 HELIX 6 6 GLY A 255 ALA A 257 5 3 HELIX 7 7 HIS A 266 GLU A 270 5 5 SHEET 1 A 4 LYS A1006 SER A1011 0 SHEET 2 A 4 ASN A1021 PHE A1030 -1 O SER A1028 N LYS A1006 SHEET 3 A 4 PHE A1062 PHE A1070 -1 O PHE A1070 N ASN A1021 SHEET 4 A 4 GLU A1050 HIS A1051 -1 N GLU A1050 O TYR A1067 SHEET 1 B 4 LYS A1006 SER A1011 0 SHEET 2 B 4 ASN A1021 PHE A1030 -1 O SER A1028 N LYS A1006 SHEET 3 B 4 PHE A1062 PHE A1070 -1 O PHE A1070 N ASN A1021 SHEET 4 B 4 SER A1055 PHE A1056 -1 N SER A1055 O TYR A1063 SHEET 1 C 4 GLU A1044 ARG A1045 0 SHEET 2 C 4 ILE A1035 LYS A1041 -1 N LYS A1041 O GLU A1044 SHEET 3 C 4 TYR A1078 HIS A1084 -1 O ARG A1081 N ASP A1038 SHEET 4 C 4 LYS A1091 TRP A1095 -1 O LYS A1091 N VAL A1082 SHEET 1 D 8 THR A 46 PHE A 49 0 SHEET 2 D 8 LEU A 35 ASP A 41 -1 N ASP A 41 O THR A 46 SHEET 3 D 8 ALA A 24 LEU A 32 -1 N LEU A 32 O LEU A 35 SHEET 4 D 8 HIS A 7 PHE A 18 -1 N ILE A 15 O GLN A 27 SHEET 5 D 8 PHE A 94 HIS A 105 -1 O ALA A 100 N VAL A 12 SHEET 6 D 8 PRO A 110 PHE A 118 -1 O PHE A 113 N GLY A 101 SHEET 7 D 8 LEU A 121 GLN A 127 -1 O LEU A 121 N PHE A 118 SHEET 8 D 8 THR A 130 PRO A 133 -1 O VAL A 132 N SER A 125 SHEET 1 E 4 GLU A 189 SER A 194 0 SHEET 2 E 4 ARG A 202 PHE A 212 -1 O HIS A 208 N TRP A 191 SHEET 3 E 4 TRP A 244 ALA A 253 -1 O VAL A 252 N LEU A 203 SHEET 4 E 4 GLN A 232 LEU A 233 -1 N GLN A 232 O THR A 249 SHEET 1 F 4 GLU A 189 SER A 194 0 SHEET 2 F 4 ARG A 202 PHE A 212 -1 O HIS A 208 N TRP A 191 SHEET 3 F 4 TRP A 244 ALA A 253 -1 O VAL A 252 N LEU A 203 SHEET 4 F 4 LEU A 237 PRO A 238 -1 N LEU A 237 O TYR A 245 SHEET 1 G 4 GLN A 226 GLU A 227 0 SHEET 2 G 4 TRP A 218 ARG A 223 -1 N ARG A 223 O GLN A 226 SHEET 3 G 4 LEU A 260 LYS A 265 -1 O LYS A 265 N TRP A 218 SHEET 4 G 4 ILE A 274 TYR A 277 -1 O LEU A 276 N CYS A 262 SSBOND 1 CYS A 102 CYS A 167 1555 1555 2.05 SSBOND 2 CYS A 207 CYS A 262 1555 1555 1.99 SSBOND 3 CYS A 1025 CYS A 1080 1555 1555 2.01 LINK C1 NAG A 1 ND2 ASN A 20 1555 1555 1.66 CISPEP 1 PRO A 1000 ILE A 1001 0 -1.30 CISPEP 2 HIS A 1031 PRO A 1032 0 3.60 CISPEP 3 LYS A 91 TYR A 92 0 6.33 CISPEP 4 GLY A 136 CYS A 137 0 -10.30 CISPEP 5 CYS A 137 GLY A 138 0 8.06 CISPEP 6 VAL A 182 HIS A 183 0 -18.02 CISPEP 7 TYR A 213 PRO A 214 0 6.02 CRYST1 53.724 87.087 88.808 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018614 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011260 0.00000